High Abundance of genus Prevotella in the gut of perinatally HIV-infected children is associated with IP-10 levels despite therapy
- PMID: 30518941
- PMCID: PMC6281660
- DOI: 10.1038/s41598-018-35877-4
High Abundance of genus Prevotella in the gut of perinatally HIV-infected children is associated with IP-10 levels despite therapy
Abstract
Perinatal HIV infection is characterized by faster HIV disease progression and higher initial rate of HIV replication compared to adults. While antiretroviral therapy (ART) has greatly reduced HIV replication to undetectable levels, there is persistent elevated inflammation associated with HIV disease progression. Alteration of gut microbiota is associated with increased inflammation in chronic adult HIV infection. Here, we aim to study the gut microbiome and its role in inflammation in treated and untreated HIV-infected children. Examination of fecal microbiota revealed that perinatally infected children living with HIV had significantly higher levels of genus Prevotella that persisted despite ART. These children also had higher levels of soluble CD14 (sCD14), a marker of microbial translocation, and IP-10 despite therapy. The Prevotella positively correlated with IP-10 levels in both treated and untreated HIV-infected children, while genus Prevotella and species Prevotella copri was inversely associated with CD4 count. Relative abundance of genus Prevotella and species Prevotella copri showed positive correlation with sCD14 in ART-suppressed perinatally HIV-infected children. Our study suggests that gut microbiota may serve as one of the driving forces behind the persistent inflammation in children despite ART. Reshaping of microbiota using probiotics may be recommended as an adjunctive therapy along with ART.
Conflict of interest statement
The authors declare no competing interests.
Figures







Similar articles
-
Distinct gut microbiota profile in antiretroviral therapy-treated perinatally HIV-infected patients associated with cardiac and inflammatory biomarkers.AIDS. 2019 May 1;33(6):1001-1011. doi: 10.1097/QAD.0000000000002131. AIDS. 2019. PMID: 30946154
-
Differential effects of antiretrovirals on microbial translocation and gut microbiota composition of HIV-infected patients.J Int AIDS Soc. 2017 Mar 9;20(1):21526. doi: 10.7448/IAS.20.1.21526. J Int AIDS Soc. 2017. PMID: 28362071 Free PMC article.
-
Impact of HIV Infection and Anti-Retroviral Therapy on the Immune Profile of and Microbial Translocation in HIV-Infected Children in Vietnam.Int J Mol Sci. 2016 Aug 2;17(8):1245. doi: 10.3390/ijms17081245. Int J Mol Sci. 2016. PMID: 27490536 Free PMC article.
-
Altered gut microbiome composition in HIV infection: causes, effects and potential intervention.Curr Opin HIV AIDS. 2018 Jan;13(1):73-80. doi: 10.1097/COH.0000000000000429. Curr Opin HIV AIDS. 2018. PMID: 29045252 Review.
-
HIV-induced alteration in gut microbiota: driving factors, consequences, and effects of antiretroviral therapy.Gut Microbes. 2014 Jul 1;5(4):562-70. doi: 10.4161/gmic.32132. Epub 2014 Jul 31. Gut Microbes. 2014. PMID: 25078714 Review.
Cited by
-
Gut microbiota dysbiosis is associated with worse emotional states in HIV infection.J Neurovirol. 2021 Apr;27(2):228-238. doi: 10.1007/s13365-020-00933-1. Epub 2021 Mar 2. J Neurovirol. 2021. PMID: 33651324 Free PMC article.
-
Gut Microbiome Changes Associated With HIV Infection and Sexual Orientation.Front Cell Infect Microbiol. 2020 Sep 24;10:434. doi: 10.3389/fcimb.2020.00434. eCollection 2020. Front Cell Infect Microbiol. 2020. PMID: 33102244 Free PMC article.
-
Early changes in the gut microbiome among HIV-infected Individuals in Uganda initiating daily TMP/SMX.medRxiv [Preprint]. 2024 Oct 7:2024.10.07.24315002. doi: 10.1101/2024.10.07.24315002. medRxiv. 2024. PMID: 39417122 Free PMC article. Preprint.
-
BugSigDB captures patterns of differential abundance across a broad range of host-associated microbial signatures.Nat Biotechnol. 2024 May;42(5):790-802. doi: 10.1038/s41587-023-01872-y. Epub 2023 Sep 11. Nat Biotechnol. 2024. PMID: 37697152 Free PMC article.
-
A Listeria monocytogenes Bacteriocin Can Target the Commensal Prevotella copri and Modulate Intestinal Infection.Cell Host Microbe. 2019 Nov 13;26(5):691-701.e5. doi: 10.1016/j.chom.2019.10.016. Cell Host Microbe. 2019. PMID: 31726031 Free PMC article.
References
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Research Materials